Anjali Kulkarni

Dr. Anjali Kulkarni

University of Ottawa, Ottawa, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2023 in Journal of Obstetrics and Gynaecology Canada
Verified
Journal Article
Closed access
AKAnjali Kulkarni
Anjali Kulkarni
ACAl Covens
Al Covens
NDNancy Durand
Nancy Durand
ZGZeina Ghorab
Zeina Ghorab
LGLilian T. Gien
Lilian T. Gien
RKRachel Kupets
Rachel Kupets

13 June 2024 in Journal of Obstetrics and Gynaecology Canada
Verified
Journal Article
Open access
MMMallika Makkar
Mallika Makkar
RHRebekah Hunter
Rebekah Hunter
AKAnjali Kulkarni
Anjali Kulkarni
JNJulie M.V. Nguyen
Julie M.V. Nguyen
Objectives: Postoperative cognitive decline (POCD) is characterised by deficits in attention, memory, executive function, and information processing that persist beyond the early postoperative period. Its incidence ranges from 10%-25% after noncardiac surgery. Limited literature exists on POCD after gynecologic oncology surgery. Our primary objective was to identify the incidence of POCD among patients 55 years or older undergoing major gynecologic oncology surgery. Methods: This mixed-methods, prospective, observational cohort study followed patients 55 years or older who underwent surgery for gynecologic malignancies between February and July 2022. Semistructured interviews and the Mini-Mental State Exam (MMSE) were administered before surgery as well as 1 and 3 months after. Assessments were delivered virtually and in-person in the context of the COVID-19 pandemic. POCD was defined as >2-point decline from baseline MMSE score. Results: Twenty-four patients participated; 19 completed the 1-month follow-up, and 15 completed the 3-month follow-up. The average age was 64 (range: 56-90). The mean preoperative MMSE score was 16.6 out of 17 (virtual) and 12.9 out of 13 (in-person). Two patients had a 1-point decline in their 1-month MMSE score; both recovered by 3 months. One patient had a 1-point decline in their 3 month MMSE score. Semi-structured interviews revealed common themes of "brain fog" at the 1-month follow-up and mild, persistent attention and word-finding deficits at 3 months postoperatively. Conclusions: This study's qualitative component captured subtle subjective findings suggestive of potential POCD. Larger studies are required, and a more extensive neuropsychological test battery may be required to elicit subtle findings not clearly reflected by MMSE scores.

7 July 2023 in Cancer Medicine
Verified
Journal Article
Open access
AKAnjali Kulkarni
Anjali Kulkarni
NWNatalie Andrews Wright
Natalie Andrews Wright
AFA. N. Forget
A. N. Forget
TRT. Ramsay
T. Ramsay
RMR. Mallick
R. Mallick
JWJ. I. Weberpals
J. I. Weberpals
Purpose: The objective of this study is to determine primary survival endpoints in women with recurrent and metastatic endometrial carcinoma (RMEC) treated with progestins. Methods: A retrospective chart review was conducted at The Ottawa Hospital using electronic medical records. Inclusion criteria were a diagnosis of RMEC between 2000 and 2019, endometrioid histology, and >= one line of progestin treatment. Progression-free survival (PFS) and overall survival (OS) were estimated using the Kaplan-Meier method. Results: Of 2342 cases reviewed, 74 met inclusion criteria. Sixty-six (88.0%) patients received megestrol acetate and 9 (12.0%) received a progestin alternative. The distribution of tumors by grade was: 1: 25 (33.3%), 2: 30 (40.0%), and 3: 20 (26.7%). The PFS and OS for the entire study sample was 14.3 months (95% CI 6.2-17.9) and 23.3 months (14.8-36.8), respectively. The PFS for patients with Grade 1-2 RMEC was 15.7 months (8.0, 19.5), compared to 5.0 months (3.0, 23.0) with Grade 3 disease. The OS for patients with Grade 1-2 versus Grade 3, was 25.9 months (15.3, 40.3) versus 12.5 months (5.7, 35.9), respectively. Thirty-four (45.9%) and 40 (54.1%) patients were treated with 0 and >= 1 line of chemotherapy. The PFS for chemotherapy-naive patients was 17.9 months (14.3, 27.0), versus 6.2 months (3.9, 14.8) following >= 1 line of treatment. The OS was 29.1 months (17.9, 61.1) for chemotherapy-naive patients versus 23.0 months (10.5, 37.6) for patients previously exposed. Conclusions: This real-world data on RMEC suggests there is a role for progestins in select subgroups of women. The PFS for chemotherapy-naive patients was 17.9 months (14.3, 27.0), versus 6.2 months (3.9, 14.8) following >= 1 line of treatment. The OS was 29.1 months (17.9, 61.1) for chemotherapy-OS was 29.1 months (17.9, 61.1) for chemotherapy-naive patients versus 23.0 months (10.5, 37.6) for patients previously exposed.

15 June 2026 in Current Oncology
Verified
Journal Article
Open access
PDF file
LSLina Salman
Lina Salman
AKAnjali Kulkarni
Anjali Kulkarni
JMJacob D. McGee
Jacob D. McGee
We aimed to evaluate the impact of malnutrition on post-operative mortality and complications in patients undergoing surgery for ovarian cancer (OC). In this retrospective cohort study utilizing the ACS NSQIP database (2013-2022), all individuals with a diagnosis of OC were included. Patients were classified as having “malnutrition” if they met any of the following: (1) pre-operative albumin level <3.5 g/dL; (2) ≥10% weight loss over 6 months + BMI = 18.5–20 kg/m2 in patients <70 years old or BMI = 18.5–22 kg/m2 in patients ≥70 years); and (3) BMI < 18.5. Baseline characteristics, 30-day post-operative mortality and complications were compared between “malnutrition” and “no malnutrition” groups. Of the 20,174 included, 8744 (43.3%) had malnutrition and 11,430 (56.7%) had no malnutrition. The malnutrition group had longer total length of hospital-stay (mean days 4.78 vs. 4.17, p < 0.0001), higher rates of venous thromboembolism, and higher cardiac morbidity compared to “no malnutrition”. On univariate analysis, mortality was higher in the “malnutrition” group (0.8% vs. 0.3%, p < 0.0001). This remained significant after adjusting for potential confounders (aOR 2.92, 95% CI 1.92–4.43, p < 0.0001). In conclusion, in patients undergoing surgery for OC, malnutrition increased the risk of post-operative mortality and complications. Malnutrition assessment should be integrated in pre-operative counseling in patients undergoing surgery for OC.